Home
Market News
Breaking stock market headlines
Earnings Flash
Breaking coverage of earnings reports, forecasts & dividend updates
Trends
Market movers, trading patterns & key market indicators
Disclosures
Official filings & reports from listed Japanese companies
Explorer
Stock lists filtered by fundamental & technical metrics
MEIDENSHA, The Current Fiscal Year Ordinary Profit Revised Upward by 19%, Raises Record High Profit Forecast
6508 MEIDENSHA CORPORATION 【J-GAAP】
Earnings ReportMEIDENSHA CORPORATION <6508> [TSE Prime] announced its financial results after the market closed on January 31st (15:30). The consolidated ordinary profit for the cumulative third quarter of the fiscal year ending March 2025 (April to December) surged 16 times that of the same period last year, reaching 6.72 billion yen.
In addition, the full-year consolidated ordinary profit has been revised upward 19.4%, from the previous forecast of 15.5 billion yen to 18.5 billion yen (compared to 13.3 billion yen in the previous period), increasing the growth rate from 15.8% to 38.2%, further surpassing the previous forecast of record-high profits for two consecutive terms.
Based on the full-year plan announced by the company after the upward revision, our estimate of the consolidated ordinary profit for the October to March period (2H) is expected to increase 21.8%, from the previous forecast of 13.7 billion yen to 16.7 billion yen (compared to 15 billion yen in the same period of the previous year), turning to a 11.7% increase in the consolidated ordinary profit outlook.
In the most recent three-month period, from October to December (3Q), the consolidated ordinary profit surged 2.4 times that of the same period last year, reaching 4.97 billion yen. The operating profit margin improved from 3.5% in the same period last year to 5.7%.
Kabutan News
Actual Results
Fiscal Year | Revenue | Operating Profit | Ordinary Profit | Net Profit | Adj. EPS | Progress Rate vs. First Half | Announce | Accounting Standards |
---|---|---|---|---|---|---|---|---|
Apr - Dec, 2022 | 170,009 | -4,692 | -4,269 | -2,582 | -56.9 | ー | Jan 31, 2023 | J-GAAP |
Apr - Dec, 2023 | 183,918 | -79 | 424 | 1,641 | 36.2 | 3.2 | Jan 31, 2024 | J-GAAP |
Apr - Dec, 2024 | 191,083 | 5,990 | 6,722 | 5,931 | 130.8 | 36.3 | Jan 31, 2025 | J-GAAP |
YoY | +3.9% | - | +1,485.4% | +261.4% | +261.3% |
Guidance Update
Second Half Update
Fiscal Year | Revenue | Operating Profit | Ordinary Profit | Net Profit | Adj. EPS | Adj. Dividend | Announce | Accounting Standards |
---|---|---|---|---|---|---|---|---|
Oct - Mar, 2024 Prev | 179,901 | 14,091 | 13,757 | 9,406 | 207.3 | - | Oct 28, 2024 | J-GAAP |
Oct - Mar, 2024 New | 184,901 | 16,591 | 16,757 | 11,906 | 262.4 | - | Jan 31, 2025 | J-GAAP |
Revision Rate | +2.8% | +17.7% | +21.8% | +26.6% | +26.6% |
Full Year Update
Fiscal Year | Revenue | Operating Profit | Ordinary Profit | Net Profit | Adj. EPS | Adj. Dividend | Announce | Accounting Standards |
---|---|---|---|---|---|---|---|---|
Mar, 2025 Prev | 300,000 | 16,000 | 15,500 | 11,500 | 253.5 | - | Oct 28, 2024 | J-GAAP |
Mar, 2025 New | 305,000 | 18,500 | 18,500 | 14,000 | 308.6 | - | Jan 31, 2025 | J-GAAP |
Revision Rate | +1.7% | +15.6% | +19.4% | +21.7% | +21.7% |
Current Period Guidance
Second Half Results
Fiscal Year | Revenue | Operating Profit | Ordinary Profit | Net Profit | Adj. EPS | Adj. Dividend | Announce | Accounting Standards |
---|---|---|---|---|---|---|---|---|
Oct - Mar, 2023 | 168,833 | 15,097 | 15,007 | 12,821 | 282.6 | 50 | May 10, 2024 | J-GAAP |
Oct - Mar, 2024 Guidance | 184,901 | 16,591 | 16,757 | 11,906 | 262.4 | - | Jan 31, 2025 | J-GAAP |
YoY | +9.5% | +9.9% | +11.7% | -7.1% | -7.1% |
Current Period Guidance
Fiscal Year | Revenue | Operating Profit | Ordinary Profit | Net Profit | Adj. EPS | Adj. Dividend | Announce | Accounting Standards |
---|---|---|---|---|---|---|---|---|
Mar, 2023 | 272,578 | 8,539 | 8,823 | 7,128 | 157.1 | 50 | May 12, 2023 | J-GAAP |
Mar, 2024 | 287,880 | 12,731 | 13,385 | 11,205 | 247.0 | 75 | May 10, 2024 | J-GAAP |
Mar, 2025 Guidance | 305,000 | 18,500 | 18,500 | 14,000 | 308.6 | - | Jan 31, 2025 | J-GAAP |
YoY | +5.9% | +45.3% | +38.2% | +24.9% | +24.9% |
Quarterly Results
Fiscal Year | Revenue | Operating Profit | Ordinary Profit | Net Profit | Adj. EPS | Operating Profit Margin | Announce | Accounting Standards |
---|---|---|---|---|---|---|---|---|
Oct - Dec, 2023 | 64,871 | 2,287 | 2,046 | 3,257 | 71.8 | 3.5 | Jan 31, 2024 | J-GAAP |
Jan - Mar, 2024 | 103,962 | 12,810 | 12,961 | 9,564 | 210.8 | 12.3 | May 10, 2024 | J-GAAP |
Apr - Jun, 2024 | 54,975 | -896 | 213 | 1,017 | 22.4 | -1.6 | Jul 31, 2024 | J-GAAP |
Jul - Sep, 2024 | 65,124 | 2,805 | 1,530 | 1,077 | 23.8 | 4.3 | Oct 28, 2024 | J-GAAP |
Oct - Dec, 2024 | 70,984 | 4,081 | 4,979 | 3,837 | 84.6 | 5.7 | Jan 31, 2025 | J-GAAP |
YoY | +9.4% | +78.4% | +143.4% | +17.8% | +17.8% |
Related Articles
WELLNET, First Half Ordinary Profit Increases by 45%, Oct-Dec Ordinary Profit Increases by 29%
TOHO SYSTEM SCIENCE, Apr-Dec (Cumulative 3Q) Ordinary Profit Increases by 6%
Temairazu, First Half Ordinary Profit Increases by 9%, Oct-Dec Ordinary Profit Increases by 11%
KUNIMINE INDUSTRIES, Oct-Dec (3Q) Ordinary Profit Increases by 24%
Tokyo Kiraboshi Financial, Apr-Dec (Cumulative 3Q) Ordinary Profit Increases by 13%, Oct-Dec Ordinary Profit Increases by 31%
Sumitomo Pharma, The Current Fiscal Year Net Income Turns to Profit, Exceeds Expectations
TDSE, The Current Fiscal Year Ordinary Profit Revised Upward by 35%
NSK, Apr-Dec (Cumulative 3Q) Net Income Decreases by 17%, Oct-Dec Net Income Decreases by 52%
ZEON, The Current Fiscal Year Ordinary Profit Revised Upward to an Unexpected 11% Increase
ZOZO, Apr-Dec (Cumulative 3Q) Ordinary Profit Increases by 13%, Oct-Dec Ordinary Profit Increases by 27%